ID

43210

Beschrijving

ODM derived from http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Link

http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Trefwoorden

  1. 16-02-12 16-02-12 -
  2. 13-04-14 13-04-14 - Julian Varghese
  3. 10-08-14 10-08-14 - Martin Dugas
  4. 20-09-21 20-09-21 -
Geüploaded op

20 september 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility NCT00334295 Metastatic Endometrial Carcinoma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI-1
C0001779
Female Gender
Beschrijving

Female Gender

Datatype

boolean

Alias
UMLS CUI-1
C0086287
Histologically confirmed, recurrent or metastatic endometrial carcinoma
Beschrijving

Metastatic endometrial carcinoma

Datatype

boolean

Alias
UMLS CUI-1
C0813148
Postmenopausal
Beschrijving

Postmenopausal

Datatype

boolean

Alias
UMLS CUI-1
C0232970
Hormonreceptor positive tumor
Beschrijving

Hormonreceptor positive tumor

Datatype

boolean

Alias
UMLS CUI-1
C1563119
Exclusion criteria
Beschrijving

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Pre-treatment with Fulvestrant
Beschrijving

Pre-treatment with Fulvestrant

Datatype

boolean

Alias
UMLS CUI-1
C1550147
Previous endocrine therapy of the endometrial carcinoma
Beschrijving

Previous endocrine therapy

Datatype

boolean

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0279025
Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
Beschrijving

Previous malignancy

Datatype

boolean

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0006826

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI-1)
Female
Item
Female Gender
boolean
C0086287 (UMLS CUI-1)
Metastatic endometrial carcinoma
Item
Histologically confirmed, recurrent or metastatic endometrial carcinoma
boolean
C0813148 (UMLS CUI-1)
Postmenopausal
Item
Postmenopausal
boolean
C0232970 (UMLS CUI-1)
Hormonreceptor positive tumor
Item
Hormonreceptor positive tumor
boolean
C1563119 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Pre-treatment with Fulvestrant
Item
Pre-treatment with Fulvestrant
boolean
C1550147 (UMLS CUI-1)
Previous endocrine therapy
Item
Previous endocrine therapy of the endometrial carcinoma
boolean
C0262926 (UMLS CUI-1)
C0279025 (UMLS CUI-2)
Previous malignancy
Item
Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
boolean
C0262926 (UMLS CUI-1)
C0006826 (UMLS CUI-2)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial